Arrhythmic Risk Stratification by Cardiovascular Magnetic Resonance Imaging in Patients With Nonischemic Cardiomyopathy
Open Access
Abstract
No abstract availableKeywords
Funding Information
- Medical Research Council
- National Heart and Lung Institute
- Rosetrees Trust
This publication has 34 references indexed in Scilit:
- Rationale and study protocol for the BRITISH randomized trial (Using cardiovascular magnetic resonance identified scar as the benchmark risk indication tool for implantable cardioverter defibrillators in patients with nonischemic cardiomyopathy and severe systolic heart failure)American Heart Journal, 2023
- Risk of Arrhythmic Death in Patients With Nonischemic CardiomyopathyJACC, 2023
- Heart Failure Burden by Autopsy, Guideline-Directed Medical Therapy, and ICD Utilization Among Sudden DeathsJACC: Clinical Electrophysiology, 2022
- 2022 AHA/ACC/HFSA Guideline for the Management of Heart FailureJACC, 2022
- Myocardial Fibrosis Predicts Ventricular Arrhythmias and Sudden Death After Cardiac Electronic Device ImplantationJACC, 2022
- Scar channels in cardiac magnetic resonance to predict appropriate therapies in primary preventionHeart Rhythm, 2021
- Improved Risk Stratification for Ventricular Arrhythmias and Sudden Death in Patients With Nonischemic Dilated CardiomyopathyJACC, 2021
- Myocardial Fibrosis as a Predictor of Sudden Death in Patients With Coronary Artery DiseaseJACC, 2021
- Long-Term Outcomes of Implantable Cardioverter-Defibrillator Therapy in the SCD-HeFTJACC, 2020
- Late Gadolinium Enhancement and the Risk for Ventricular Arrhythmias or Sudden Death in Dilated CardiomyopathyJACC: Heart Failure, 2017